Boldine induces cell cycle arrest and apoptosis in T24 human bladder cancer cell line via regulation of ERK, AKT, and GSK-3β
- 1 January 2014
- journal article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 32 (1) , 36.e1-36.e9
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Chemotherapy in advanced bladder cancer: current status and futureJournal of Hematology & Oncology, 2011
- Treatment of uncommon malignant tumours of the bladderCurrent Opinion in Urology, 2011
- Small cell cancer of the bladder: pathology, diagnosis, treatment and prognosisBulletin du Cancer, 2009
- The present and future burden of urinary bladder cancer in the worldWorld Journal of Urology, 2009
- The global burden of urinary bladder cancerScandinavian Journal of Urology and Nephrology, 2008
- Early bladder cancer: concept, diagnosis, and managementInternational Journal of Clinical Oncology, 2006
- Treatment of Invasive Bladder Cancer: Lessons from the Past and Perspective for the FutureJapanese Journal of Clinical Oncology, 2004
- Boldo and boldine: an emerging case of natural drug developmentPharmacological Research, 1994
- New Colorimetric Cytotoxicity Assay for Anticancer-Drug ScreeningJNCI: Journal of the National Cancer Institute, 1990
- Established cell line of urinary bladder carcinoma (T24) containing tumour‐specific antigenInternational Journal of Cancer, 1973